U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270367) titled 'Finerenone and Cardiac Remodeling' on Nov. 13.
Brief Summary: The goal of this clinical trial is to learn if the drug finerenone (Karendia) can improve heart function in participants who are at risk for heart and kidney disease.
The main question it aims to answer is whether adding finerenone to standard-of-care heart failure medical therapies will beneficially alter the heart structure and function of people who have risk factors for heart and kidney complications and whose left side of the heart is enlarged.
The researchers will compare finerenone to a placebo (a look-alike substance that contains no drug) to see if finerenone im...